Exagen | 4:持股变动声明-高管 Adawi Kamal
03/07 05:12
Exagen | 4:持股变动声明-高管 ABALLI JOHN
03/05 05:12
Exagen | 4:持股变动声明-高管 Adawi Kamal
02/23 05:20
Exagen | 4:持股变动声明-高管 ABALLI JOHN
02/23 05:14
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Laurence W. Lytton(6.8%)
02/15 03:49
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(8.8%),Roderick Wong, M.D.(8.8%)
02/14 20:16
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Stonepine Capital Management, LLC(3.9%),Stonepine Capital, L.P(3.9%)等
02/14 05:42
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-James L.L. Tullis(10.7%),Tullis-Dickerson Capital Focus III, L.P.(6.5%)等
02/13 19:14
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)
02/10 06:15
Exagen | 4:持股变动声明-高管 Adawi Kamal
02/09 05:09
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-Cowen Financial Products LLC(5.27%)
02/03 04:21
Exagen | SC 13G/A:超过5%持股股东披露文件(修正)-NMSIC Co-Investment Fund, L.P.(13.55%),Sun Mountain Capital Partners, L.L.C.(13.55%)
01/22 13:00
Exagen | 4:持股变动声明-高管 ABALLI JOHN
2023/10/19 04:05
Exagen | 4:持股变动声明-高管 ABALLI JOHN
2023/09/07 05:05
Exagen | 4:持股变动声明-董事 Kim Paul
2023/07/27 04:06
Exagen | 3:首次持股声明-董事 Kim Paul
2023/07/27 04:05
Exagen | 4:持股变动声明-股东 TULLIS JAMES L L
2023/06/21 05:04
Exagen | 4:持股变动声明-高管 Nova Tina Susan
2023/06/21 04:30
Exagen | 4:持股变动声明-董事 Stokes Frank
2023/06/14 04:36
Exagen | 4:持股变动声明-董事 Birk Brian
2023/06/14 04:36
暂无数据
暂无数据